首页|可溶性人基质裂解素2(sST2)在CAP血清中的表达及临床意义

可溶性人基质裂解素2(sST2)在CAP血清中的表达及临床意义

Expression and clinical significance of soluble human stromelysin 2(sST2)in serum of patients with pneumonia

扫码查看
目的 分析可溶性人基质裂解素2(soluble suppression of tumorigenicity 2,sST2)社区获得性肺炎(community-acquired pneumonia,CAP)血清中的表达及临床意义.方法 选择2023年4月至2023月7月我院收治的56例CAP患者为对象,预后恢复临床稳定性41例为对照组,未恢复临床稳定性15例为观察组.检测sST2水平,收集性别、年龄、吸烟史、白细胞计数(leukocyte count,WBC)、中性粒细胞(neutrophil,Neu)、淋巴细胞(lymphocyte,Lym)、C 反应蛋白(C reactive protein,CRP)、N-末端脑利钠肤前体(N-terminal pro-brain natriuretic peptide,NT-proBNP)、降钙素原(procalcitonin,PCT)临床资料,采用多因素Logistics回归分析临床稳定性的影响因素,绘制ROC曲线分析sST2水平对临床稳定性.结果 观察组年龄(59.88±9.20)岁、CRP(53.15±10.24)mg/ml、PCT(1.20±0.24)ng/ml 及 sST2(73.61± 8.16)ng/ml、PSI 分级Ⅳ~Ⅴ10 例(66.67%)高于对照组年龄(54.10±9.16)岁、CRP(12.30±2.16)mg/ml、PCT(0.08±0.02)ng/ml 及 sST2(64.87±6.25)ng/ml 和 PSI 分级Ⅳ~Ⅴ 15 例(36.59%)(P<0.05).多因素Logistics 回归分析显示,CRP(OR=1.042)、PCT(OR=0.682)及 sST2(OR=0.848)是 CAP 患者临床稳定性的影响因素(P<0.05).ROC曲线结果显示sST2水平AUC=0.815,95%CI:0.688~0.906;CRP水平AUC=0.733,95%CI:0.598~0.843;PCT 水平 AUC=0.798,95%CI:0.709~0.870.结论 CAP sST2 水平升高;入院时sST2水平可作为预测CAP恢复临床稳定性的生物标志物.
Objective To analyze the expression and clinical significance of soluble human matrix lysate 2(sST2)in serum of patients with community-acquired pneumonia(CAP).Methods All of 56 patients with community-acquired pneumonia(CAP)admitted to our hospital from April 2023 to July 2023 were included as the research group,and 41 cases of clinical stability recovery were divided into control group and 15 cases of clinical stability recovery were observed group.The patient's sST2 level was detected,and the general data such as gender,age and smoking history and clinical data,including white blood cell count(WBC),neutrophil(Neu),lymphocyte(Lym),C-reactive protein(CRP),N-terminal pro-brain natriuretic peptide(NT-proBNP),and so on,were collected by using electronic medical records.Multivariate logistics regression was used to analyze the influencing factors of clinical stability,and the ROC curve was drawn to analyze the predictive value of sST2 level on clinical stability.Results The age(59.88±9.20)years old,CRP(53.15± 10.24)mg/ml,PCT(1.20±0.24)ng/ml,sST2(73.61±8.16)ng/ml,PSI grade Ⅳ~Ⅴ in 10 cases(66.67%)in observation group were higher than those in control group(54.10±9.16)years old,CRP(12.30± 2.16)mg/ml,PCT(0.08±0.02)ng/ml,sST2(64.87±6.25)ng/ml and PSI classification Ⅳ~Ⅴ(P<0.05)in 10 cases(66.67%).Multivariate logistics regression analysis showed that CRP(OR=1.042),PCT(OR=0.682)and sST2(OR=0.848)were the influencing factors for the clinical stability of elderly CAP patients(P<0.05).The ROC curve shows that AUC of sST2 level is 0.815,and 95%CI is 0.688-0.906.The AUC of CRP level was 0.733,and 95%CI was 0.598-0.843.The AUC of PCT level is 0.798,and 95%CI was 0.709-0.870.Conclusion The level of sST2 in CAP patients is significantly higher.The level of sST2 at admission can be used as a biomarker to predict the recovery of clinical stability in CAP patients.

Soluble human matrix lysin 2Community-acquired pneumoniaC-reactive proteinProcalcitoninPredicted value

叶瑞兴、张娟、龚彩平、王发雄、唐雄

展开 >

510000 广东,南方医科大学附属广东省人民医院/广东省医学科学院检验科

510000 广东,南方医科大学附属广东省人民医院/广东省医学科学院呼吸内科

可溶性人基质裂解素2 社区获得性肺炎 C反应蛋白 降钙素原 预测价值

广东省科技创新战略专项资金立项项目

pdjh2022b5987

2023

中华肺部疾病杂志(电子版)
中华医学会

中华肺部疾病杂志(电子版)

CSTPCD
影响因子:1.358
ISSN:1674-6902
年,卷(期):2023.16(6)
  • 4